The Valley Desk

ArticleMultiple sclerosis and related disordersPublished

Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Multiple sclerosis and related disorders
Published
Subject terms
Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Oxadiazoles; Thiazoles; Indans; Relapsing Multiple Sclerosis; Ponesimod; Matching-adjusted Indirect Comparison; Ozanimod
PubMed ID
36791623
Added to directory
Source checked

Report a correction or request removal